In addition, P-selectin has been shown to be associated with increased risk of arterial and venous thromboembolism in patients with [36, 37] and without cancer, [38] and with portal vein thrombosis in patients with cirrhosis [39]. This evidence concerns the gene SELP and Portal vein thrombosis.